MDT

98.58

+2.77%↑

A

145.93

-0.38%↓

VEEV

220.72

-1.98%↓

HQY

87

+2.64%↑

NEOG

9.6

+3.9%↑

MDT

98.58

+2.77%↑

A

145.93

-0.38%↓

VEEV

220.72

-1.98%↓

HQY

87

+2.64%↑

NEOG

9.6

+3.9%↑

MDT

98.58

+2.77%↑

A

145.93

-0.38%↓

VEEV

220.72

-1.98%↓

HQY

87

+2.64%↑

NEOG

9.6

+3.9%↑

MDT

98.58

+2.77%↑

A

145.93

-0.38%↓

VEEV

220.72

-1.98%↓

HQY

87

+2.64%↑

NEOG

9.6

+3.9%↑

MDT

98.58

+2.77%↑

A

145.93

-0.38%↓

VEEV

220.72

-1.98%↓

HQY

87

+2.64%↑

NEOG

9.6

+3.9%↑

Search

ResMed Inc

Closed

SectorHealthcare

259.78 1.9

Overview

Share price change

24h

Current

Min

251.28

Max

259.96

Key metrics

By Trading Economics

Income

-31M

349M

Sales

-12M

1.3B

P/E

Sector Avg

26.391

90.831

Dividend yield

0.87

Profit margin

26.096

Employees

10,600

EBITDA

-29M

503M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+15.44% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.87%

2.20%

Next Earnings

29 Jan 2026

Next Dividend date

19 Mar 2026

Next Ex Dividend date

12 Feb 2026

Market Stats

By TradingEconomics

Market Cap

-193M

38B

Previous open

257.88

Previous close

259.78

News Sentiment

By Acuity

33%

67%

68 / 361 Healthcare

ResMed Inc Chart

Past performance is not a reliable indicator of future results.

Related News

14 Jan 2026, 22:41 UTC

Acquisitions, Mergers, Takeovers

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

15 Jan 2026, 00:00 UTC

Earnings

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

14 Jan 2026, 23:47 UTC

Market Talk

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

14 Jan 2026, 23:44 UTC

Market Talk

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

14 Jan 2026, 23:39 UTC

Market Talk

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

14 Jan 2026, 23:32 UTC

Market Talk

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

14 Jan 2026, 22:56 UTC

Acquisitions, Mergers, Takeovers

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

14 Jan 2026, 22:53 UTC

Acquisitions, Mergers, Takeovers

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

14 Jan 2026, 22:17 UTC

Market Talk

Global Equities Roundup: Market Talk

14 Jan 2026, 22:17 UTC

Market Talk

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

14 Jan 2026, 22:09 UTC

Earnings

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

14 Jan 2026, 22:08 UTC

Earnings

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

14 Jan 2026, 22:08 UTC

Earnings

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

14 Jan 2026, 21:53 UTC

Acquisitions, Mergers, Takeovers

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

14 Jan 2026, 21:53 UTC

Acquisitions, Mergers, Takeovers

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

14 Jan 2026, 21:52 UTC

Acquisitions, Mergers, Takeovers

WuXi XDC Announces Positive Profit Alert for 2025

14 Jan 2026, 21:51 UTC

Acquisitions, Mergers, Takeovers

Citigroup Acting as Financial Advisor to WuXi XDC

14 Jan 2026, 21:51 UTC

Acquisitions, Mergers, Takeovers

WuXi XDC: Aims to Keep Listing Status of BioDlink

14 Jan 2026, 21:51 UTC

Acquisitions, Mergers, Takeovers

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

14 Jan 2026, 21:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

14 Jan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

14 Jan 2026, 21:49 UTC

Acquisitions, Mergers, Takeovers

WuXi XDC: BioDlink Offer to Cost HK$2.79B

14 Jan 2026, 21:48 UTC

Acquisitions, Mergers, Takeovers

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

14 Jan 2026, 21:48 UTC

Acquisitions, Mergers, Takeovers

WuXi XDC Makes Cash Offer for BioDlink International

14 Jan 2026, 21:13 UTC

Market Talk

Oil Retreats Late After Trump Comments on Iran -- Market Talk

14 Jan 2026, 20:30 UTC

Market Talk
Earnings

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

14 Jan 2026, 20:13 UTC

Market Talk

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

14 Jan 2026, 20:08 UTC

Market Talk

Oil Futures Extend Rally on Iran Tensions -- Market Talk

14 Jan 2026, 19:33 UTC

Market Talk

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

14 Jan 2026, 19:06 UTC

Market Talk
Earnings

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Peer Comparison

Price change

ResMed Inc Forecast

Price Target

By TipRanks

15.44% upside

12 Months Forecast

Average 294 USD  15.44%

High 345 USD

Low 260 USD

Based on 11 Wall Street analysts offering 12 month price targets forResMed Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

6

Buy

5

Hold

0

Sell

Sentiment

By Acuity

68 / 361 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat